Login

Takeda Signs Full-Building Lease for New 16-Story Tower To Be Built by BioMed Realty

Japanese Drug Giant Selects New 600,000-Square-Foot Kendall Square Building To Establish Long-Sought Campus in Cambridge, Massachusetts
In one of the biggest leases signed in Boston so far this year, Takeda agreed to occupy all 600,000 square feet of R&D and office space to be built at 585 Third St. in Kendall Square by BioMed Realty. (Takeda)
In one of the biggest leases signed in Boston so far this year, Takeda agreed to occupy all 600,000 square feet of R&D and office space to be built at 585 Third St. in Kendall Square by BioMed Realty. (Takeda)
By Matt Greenwood
Research
June 22, 2022 | 9:31 P.M.

Japanese multinational pharmaceutical company Takeda agreed to lease an entire 16-story building planned by Blackstone's BioMed Realty in Boston's Kendall Square where the company said it plans to establish a central campus at the center of the region's life science hub in Cambridge.

This news story is available exclusively to CoStar subscribers.

Watch the video to learn how you can access industry leading CRE news and the data analytics you need to drive success.

This news story is available exclusively to CoStar subscribers.

Ready to Learn More?

Sign Up For a Personalized Demo.

Sign Up For a Demo To Learn More.

Already A Subscriber? Sign In

IN THIS ARTICLE